Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29023776 | 0.92 | L3MBTL1 (0.38) | L3MBTL1SMN1; SMN2HPGDGLARECQL | |
| SCHEMBL27996379 | 0.85 | KMT2A (0.41) | L3MBTL1SMN1; SMN2HPGDGLARECQL | |
| SCHEMBL15384208 | 0.82 | LMNA (0.35) | L3MBTL1SMN1; SMN2HPGDGLARECQL | |
| SCHEMBL17320591 | 0.80 | KMT2A (0.42) | SMN1; SMN2HPGDKMT2AMEN1POLB | |
| SCHEMBL13177108 | 0.79 | KMT2A (0.42) | L3MBTL1SMN1; SMN2HPGDGLARECQL | |
| SCHEMBL17262628 | 0.78 | ATM (0.37) | SMN1; SMN2KMT2AMEN1GAAALDH1A1 | |
| SCHEMBL23578461 | 0.76 | KMT2A (0.35) | L3MBTL1HPGDKMT2AMEN1GAA | |
| SCHEMBL5133904 | 0.76 | L3MBTL1 (0.40) | L3MBTL1SMN1; SMN2HPGDGLARECQL | |
| SCHEMBL28049991 | 0.75 | L3MBTL1 (0.36) | L3MBTL1SMN1; SMN2HPGDGLARECQL | |
| SCHEMBL9411151 | 0.75 | L3MBTL1 (0.38) | L3MBTL1SMN1; SMN2HPGDGLARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119667039-A | White spirit identification method based on component dimension | 贵州习酒投资控股集团有限责任公司 | 2025-03-21 | — | — | CN | claimed |
| CN-107283566-B | Musical instrument fingerboard wood material, preparation method thereof and acoustic functional body impregnation liquid thereof | 中国林业科学研究院木材工业研究所 | 2020-11-24 | — | — | CN | claimed |
| CN-107283566-A | Musical instrument fingerboard wood materials and preparation method thereof and its acoustic function body maceration extract | 中国林业科学研究院木材工业研究所 | 2017-10-24 | — | — | CN | claimed |
| US-7572757-B1 | Method of treating a well with a gel stabilizer | BJ SERVICES COMPANY (US) | 2009-08-11 | — | — | US | claimed |
| US-7045640-B2 | Method of producing 5-formyl-2-furylboronic acid | DEGUSSA AG (DE) | 2006-05-16 | — | — | US | claimed |
| EP-1403271-B1 | Method of producing 5-formyl-2-furylboronic acid | DEGUSSA (DE) | 2005-11-16 | — | — | EP | claimed |
| US-6872754-B1 | Method for processing elastomers | WORTHAM LEON (US) | 2005-03-29 | — | — | US | claimed |
| US-20040127725-A1 | Method of producing 5-formyl-2-furylboronic acid | DEGUSSA AG (DE) | 2004-07-01 | — | — | US | claimed |
| EP-1403271-A1 | Method of producing 5-formyl-2-furylboronic acid | Degussa AG (DE) | 2004-03-31 | — | — | EP | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| EP-0788522-B1 | ACETAL DERIVATIVES OF RESOLE COMPOUNDS | LORD CORP (US) | 1999-11-10 | — | — | EP | claimed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| US-5677414-A | STORAGE STABILITY; ADHESIVES, COATINGS | LORD CORPORATION (US) | 1997-10-14 | — | — | US | claimed |
| US-5663246-A | Acetal derivatives of resole compounds | LORD CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0788522-A1 | ACETAL DERIVATIVES OF RESOLE COMPOUNDS | LORD CORPORATION (US) | 1997-08-13 | — | — | EP | claimed |
| WO-1996013536-A1 | ACETAL DERIVATIVES OF RESOLE COMPOUNDS | LORD CORPORATION (US) | 1996-05-09 | — | — | WO | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| WO-1993002383-A1 | NONLINEAR OPTICAL MATERIALS CONTAINING POLAR DISULFONE-FUNCTIONALIZED MOLECULES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-02-04 | — | — | WO | disclosed |
| US-3936438-A | INOTROPIC | WARNER-LAMBERT COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127725-A1 | Method of producing 5-formyl-2-furylboronic acid | FPR2, FPR1, FPR3 | L3MBTL1 3066/4885SMN1; SMN2 2164/4885HPGD 195/4885 |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | L3MBTL1 3650/4885SMN1; SMN2 897/4885HPGD 2113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.